Sunshine Biopharma (NASDAQ:SBFM) Posts Earnings Results, Misses Estimates By $9.94 EPS

Sunshine Biopharma (NASDAQ:SBFM) issued its quarterly earnings results on Tuesday. The company reported ($0.94) EPS for the quarter, missing analysts’ consensus estimates of $9.00 by ($9.94), Zacks reports. The firm had revenue of $8.44 million for the quarter. Sunshine Biopharma had a negative net margin of 12.07% and a negative return on equity of 16.09%.

Sunshine Biopharma Stock Performance

Shares of SBFM opened at $2.72 on Friday. The stock’s 50-day simple moving average is $2.96 and its 200 day simple moving average is $1.65. The stock has a market capitalization of $3.33 million, a price-to-earnings ratio of -0.02 and a beta of 1.38. Sunshine Biopharma has a 52-week low of $2.42 and a 52-week high of $637.20.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.